The Rise of Oral Metabolic Research: Orforglipron, Tesofensine, and the Future of Weight Management Conversations
The metabolic research space is evolving faster than ever. For years, most obesity and weight-management discussions centered around injectable GLP-1 therapies. But now, researchers are increasingly exploring oral compounds connected to: Two compounds that continue generating significant attention in these conversations are orforglipron and tesofensine. While they work through very different mechanisms, both are becoming…
